Table 2 Recurrence and survival of the present 18-patient cohort
No. | Age, y | Gender | Recurrence/metastasis after first seed implant, further treatment | TTR mo | Survival, mo |
|---|---|---|---|---|---|
1 | 72 | M | LR; 3 implants | 11/12 | 43 |
2 | 57 | F | LR; 3 implants | 10/13 | 31 |
3 | 59 | M | Brain metastases; whole brain irradiation + 2 implants | 24 | Living |
4 | 59 | M | Adrenal metastasis (R); 2 implants | 13 | Living |
5 | 73 | M | LR; 2 implants, yet failed due to hemoptysis | 15 | 15 |
6 | 70 | M | — | 12 | Living |
7 | 54 | M | LR; 2 implants + mediastinal external irradiation | 11 | 13 |
8 | 81 | M | — | 14 | 24 |
9 | 66 | F | LR; 2 implants | 17 | Living |
10 | 67 | M | Neck metastasis; 3 implants | 11/13 | 17 |
11 | 73 | M | LR; 2 implants | 14 | Living |
12 | 78 | F | L; lung metastases at 6 years after first treatment; 2 implants | 78 | Living |
13 | 65 | F | — | 0 | Living |
14 | 75 | M | Neck metastasis; 2 implants | 13 | 16 |
15 | 66 | M | — | 16 | 21 |
16 | 60 | F | Neck metastasis; 1 implant + adrenal EBRT | 0 | 11 |
17 | 57 | M | — | 0 | 12 |
18 | 64 | M | — | 0 | Living |